What is it about?
We determined the safety of a high sensitivity cardiac troponin I assay derived for 0 hour and 0/2-hour rule-out concentrations for myocardial infarction in consecutive, emergency department patients undergoing serial testing in the MERITnI trial.
Featured Image
Read the Original
This page is a summary of: Novel Mindray high sensitivity cardiac troponin I assay for single sample and 0/2-hour rule out of myocardial infarction: MERITnI study, Clinical Chemistry and Laboratory Medicine (CCLM), March 2025, De Gruyter,
DOI: 10.1515/cclm-2024-1387.
You can read the full text:
Contributors
Be the first to contribute to this page
